# ECI Pharmaceuticals, LLC – FDA Inspection, Jan 27, 2023

Source: https://www.keypedia.com/records/fda_inspections/eci-pharmaceuticals-llc/90aa198d-8a7c-4e8c-9063-8ced8707db0a
Source feed: FDA_Inspections

> FDA inspection 1195706 of ECI Pharmaceuticals, LLC, January 27, 2023. Classification: Voluntary Action Indicated (VAI). 8 citations under 21 CFR part 314. Form 483 issued. 6 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1195706
- Company Name: ECI Pharmaceuticals, LLC
- Inspection Date: 2023-01-27
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 8

## Related Documents

- [FDA Inspection 1337266 - 2026-09-24](https://www.keypedia.com/records/fda_inspections/eci-pharmaceuticals-llc/68180fe4-cdfd-41e9-b6ee-b7d5c523d0c9)
- FDA Inspection 1168612 - 2022-04-22
- FDA Inspection 1084843 - 2019-02-22
- FDA Inspection 1030111 - 2017-08-08
- [FDA Inspection 993627 - 2016-11-18](https://www.keypedia.com/records/fda_inspections/eci-pharmaceuticals-llc/f88d84cc-b551-4e5b-bddd-05b4622a6e13)

## Related Officers

- [Company Rep](https://www.keypedia.com/people/matthew-f-duff/7efbc61c-5f7a-4d2c-86d9-500291ee6789)

Company: https://www.keypedia.com/companies/eci-pharmaceuticals-llc/82443550-cfc6-4f79-b5ee-7025247b03a8

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c